4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-022636
President and CEO sold 5,510 shares at an average $0.65 ($3,576)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-14 | Sale : show line 1 in the form 10b5-1 | −2,881 | $0.63 | $1,815 | 647,923 | D |
| 2023-08-15 | Sale : show line 2 in the form 10b5-1 | −2,629 | $0.67 | $1,761 | 645,294 | D |
| Open-market sales · 5,510 sh · avg $0.65 · $3,576 | ||||||
Loading xslF345X05/form4.xml…